查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1698073

醫療營養市場－全球產業規模、佔有率、趨勢、機會和預測，按給藥途徑、應用、最終用戶、地區和競爭細分，2020-2030 年預測

Medical Nutrition Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Route of Administration, By Application, By End User, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球醫療營養市場價值為 622 億美元，預計在預測期內將實現令人印象深刻的成長，到 2030 年的複合年成長率為 7.72%。全球醫療營養市場涵蓋各種專門的營養產品和補充劑，旨在解決特定的醫療狀況和營養需求。這些產品適用於因各種健康問題（包括營養不良、慢性疾病、胃腸道疾病等）而需要客製化營養解決方案的個人。例如，根據世界衛生組織 2022 年的數據，全球約有 1.49 億 5 歲以下兒童發育遲緩，4,500 萬名兒童被認為是體重減輕。南亞次區域五歲以下兒童營養不良問題嚴重。此外，聯合國報告稱，亞洲營養不良人口從 2019 年的 3.613 億增加到 2020 年的 4.18 億，營養不良發生率從 7.9% 上升到 9.0%。醫學營養是指專門使用營養素、客製化飲食和治療性食品配方來管理特定的健康狀況、支持康復和改善整體健康。它是醫療保健的重要組成部分，針對營養不良、慢性疾病、代謝紊亂以及手術或受傷後的恢復等情況。醫療營養包括口服補充劑、腸內餵食（管飼）和常規飲食不足時的腸外營養（靜脈餵食）。它是在醫學監督下設計的，旨在解決個人營養缺乏問題，最佳化健康結果，並預防併發症。醫學營養在提高各種疾病患者的生活品質方面發揮關鍵作用。

市場概覽
預測期 2026-2030
2024 年市場規模 622億美元
2030年市場規模 964億美元
2025-2030 年複合年成長率 7.72％
成長最快的領域 口服和腸內
最大的市場 北美洲

主要市場促進因素

健康意識不斷增強

主要市場挑戰

嚴格的品質保證

主要市場趨勢

個人化營養

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球醫療營養市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依給藥途徑（口服、腸內、腸外）
    • 依應用（營養不良、代謝失調、胃腸道疾病、癌症、神經系統疾病、其他）
    • 按最終使用者（兒童、成人）
    • 按地區
    • 按公司分類（2024）
  • 產品市場圖
    • 依給藥途徑
    • 按應用
    • 按最終用戶
    • 按地區

第 6 章：北美醫療營養市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 加拿大
    • 墨西哥

第7章：歐洲醫療營養市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 英國
    • 法國
    • 義大利
    • 西班牙

第8章：亞太醫療營養市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 日本
    • 印度
    • 澳洲
    • 韓國

第 9 章：南美洲醫療營養市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 阿根廷
    • 哥倫比亞

第10章：中東與非洲醫療營養市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 合併與收購
  • 產品發布

第 13 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 14 章：競爭格局

  • Abbott Nutrition Ltd
  • Nestle Health Science SA
  • Baxter Healthcare Corp
  • B Braun SE
  • Danone SA
  • Perrigo Co PLC
  • Fresenius Kabi AG
  • AYMES Nutrition
  • Reckitt Benckiser Group PLC
  • Ajinomoto Cambrooke Inc.

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 20595

Global Medical Nutrition Market was valued at USD 62.20 billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.72% through 2030. The global medical nutrition market encompasses a diverse range of specialized nutritional products and supplements designed to address specific medical conditions and nutritional needs. These products are utilized by individuals who require tailored nutrition solutions due to various health issues, including malnutrition, chronic diseases, gastrointestinal disorders, and more. For instance, According to the World Health Organization in 2022, approximately 149 million children under the age of 5 were estimated to be stunted, while 45 million were considered wasted globally. The South Asia sub-region bears a significant burden of malnutrition among children under 5 years old. Also, the UN reports that Asia's undernourished population rose from 361.3 million in 2019 to 418.0 million in 2020, with the prevalence of undernourishment increasing from 7.9% to 9.0%. Medical nutrition refers to the specialized use of nutrients, tailored diets, and therapeutic food formulations to manage specific health conditions, support recovery, and improve overall well-being. It is an essential component of healthcare, targeting conditions such as malnutrition, chronic illnesses, metabolic disorders, and recovery from surgeries or injuries. Medical nutrition includes oral supplements, enteral feeding (tube feeding), and parenteral nutrition (intravenous feeding) when regular diets are insufficient. Designed under medical supervision, it addresses individual nutritional deficiencies, optimizes health outcomes, and prevents complications. Medical nutrition plays a pivotal role in enhancing the quality of life for patients across various medical conditions.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 62.20 Billion
Market Size 2030USD 96.40 Billion
CAGR 2025-20307.72%
Fastest Growing SegmentOral and Enteral
Largest MarketNorth America

Key Market Drivers

Rising Health Awareness

In recent years, a notable shift has occurred in how people perceive health and wellness. There is an increasing awareness of the profound connection between nutrition and well-being, which has significantly contributed to the growth of the global medical nutrition market. This heightened health consciousness is driving individuals to seek specialized nutrition solutions, making the medical nutrition market a dynamic and rapidly expanding industry. For instance, The World Health Organization (WHO) reports that the global population aged 60 and over is projected to grow substantially, increasing from approximately 1 billion in 2020 to about 1.4 billion by 2030. Furthermore, it is expected to nearly double by 2050, reaching around 2.1 billion.

Rising health awareness has prompted a paradigm shift from reactive healthcare to proactive health management. Individuals are increasingly taking charge of their well-being by adopting healthier lifestyles and actively seeking ways to prevent health issues. Medical nutrition plays a crucial role in this shift, offering a means to prevent and manage health conditions through tailored dietary interventions.

Key Market Challenges

Stringent Quality Assurance

Quality assurance is paramount in the medical nutrition market. Ensuring the safety and efficacy of these products is a complex process, with strict standards set by regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA). Adherence to these standards is essential to maintain consumer trust, which can be a challenge for smaller manufacturers and new entrants in the market.

Key Market Trends

Personalized Nutrition

Personalization is a dominant trend across the food and nutrition industry, and medical nutrition is no exception. The future of medical nutrition is increasingly individualized, with tailored solutions that account for a person's unique health status, dietary preferences, and genetics. This trend is enabled by the growing understanding of nutrigenomics, which explores how an individual's genes interact with their diet, allowing for precision nutrition recommendations.

Key Market Players

  • Abbott Nutrition Ltd
  • Nestle Health Science SA
  • Baxter Healthcare Corp
  • B Braun SE
  • Danone SA
  • Perrigo Co PLC
  • Fresenius Kabi AG
  • AYMES Nutrition
  • Reckitt Benckiser Group PLC
  • Ajinomoto Cambrooke Inc.

Report Scope:

In this report, the Global Medical Nutrition Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Medical Nutrition Market, By Route of Administration:

  • Oral and Enteral
  • Parenteral

Medical Nutrition Market, By Application:

  • Malnutrition
  • Metabolic Disorders
  • Gastrointestinal Diseases
  • Cancer
  • Neurological Diseases
  • Others

Medical Nutrition Market, By End User:

  • Pediatric
  • Adult

Medical Nutrition Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Medical Nutrition Market.

Available Customizations:

Global Medical Nutrition market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Medical Nutrition Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Route of Administration (Oral and Enteral, Parenteral)
    • 5.2.2. By Application (Malnutrition, Metabolic Disorders, Gastrointestinal Diseases, Cancer, Neurological Diseases, Others)
    • 5.2.3. By End User (Pediatric, Adult)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Product Market Map
    • 5.3.1. By Route of Administration
    • 5.3.2. By Application
    • 5.3.3. By End User
    • 5.3.4. By Region

6. North America Medical Nutrition Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Route of Administration (Oral and Enteral, Parenteral)
    • 6.2.2. By Application (Malnutrition, Metabolic Disorders, Gastrointestinal Diseases, Cancer, Neurological Diseases, Others)
    • 6.2.3. By End User (Pediatric, Adult)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Medical Nutrition Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Route of Administration
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Medical Nutrition Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Route of Administration
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Medical Nutrition Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Route of Administration
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Medical Nutrition Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Route of Administration (Oral and Enteral, Parenteral)
    • 7.2.2. By Application (Malnutrition, Metabolic Disorders, Gastrointestinal Diseases, Cancer, Neurological Diseases, Others)
    • 7.2.3. By End User (Pediatric, Adult)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Medical Nutrition Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Route of Administration
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. United Kingdom Medical Nutrition Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Route of Administration
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. France Medical Nutrition Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Route of Administration
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Medical Nutrition Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Route of Administration
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Medical Nutrition Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Route of Administration
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia-Pacific Medical Nutrition Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Route of Administration (Oral and Enteral, Parenteral)
    • 8.2.2. By Application (Malnutrition, Metabolic Disorders, Gastrointestinal Diseases, Cancer, Neurological Diseases, Others)
    • 8.2.3. By End User (Pediatric, Adult)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Medical Nutrition Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Route of Administration
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. Japan Medical Nutrition Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Route of Administration
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. India Medical Nutrition Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Route of Administration
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. Australia Medical Nutrition Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Route of Administration
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. South Korea Medical Nutrition Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Route of Administration
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. South America Medical Nutrition Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Route of Administration (Oral and Enteral, Parenteral)
    • 9.2.2. By Application (Malnutrition, Metabolic Disorders, Gastrointestinal Diseases, Cancer, Neurological Diseases, Others)
    • 9.2.3. By End User (Pediatric, Adult)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Medical Nutrition Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Route of Administration
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Medical Nutrition Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Route of Administration
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Medical Nutrition Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Route of Administration
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. Middle East and Africa Medical Nutrition Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Route of Administration (Oral and Enteral, Parenteral)
    • 10.2.2. By Application (Malnutrition, Metabolic Disorders, Gastrointestinal Diseases, Cancer, Neurological Diseases, Others)
    • 10.2.3. By End User (Pediatric, Adult)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Medical Nutrition Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Route of Administration
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Medical Nutrition Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Route of Administration
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Medical Nutrition Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Route of Administration
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User
    • 10.3.4. Kuwait Medical Nutrition Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Route of Administration
        • 10.3.4.2.2. By Application
        • 10.3.4.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Abbott Nutrition Ltd
  • 14.2. Nestle Health Science SA
  • 14.3. Baxter Healthcare Corp
  • 14.4. B Braun SE
  • 14.5. Danone SA
  • 14.6. Perrigo Co PLC
  • 14.7. Fresenius Kabi AG
  • 14.8. AYMES Nutrition
  • 14.9. Reckitt Benckiser Group PLC
  • 14.10. Ajinomoto Cambrooke Inc.

15. Strategic Recommendations

16. About Us & Disclaimer